Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Operating Margin: 2023-2025

Historic Operating Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -1,005.08%.

  • Tonix Pharmaceuticals Holding's Operating Margin fell 45391.00% to -1,005.08% in Q3 2025 from the same period last year, while for Sep 2025 it was -969.97%, marking a year-over-year increase of 28369.00%. This contributed to the annual value of -1,354.28% for FY2024, which is 16966.00% up from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Operating Margin is -1,005.08%, which was up 29.03% from -1,416.22% recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Operating Margin high stood at -551.17% for Q3 2024, and its period low was -3,501.63% during Q2 2024.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Operating Margin averaged around -1,143.86%, with its median value being -860.23% (2024).
  • Within the past 5 years, the most significant YoY rise in Tonix Pharmaceuticals Holding's Operating Margin was 208,541bps (2025), while the steepest drop was 45,391bps (2025).
  • Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's Operating Margin stood at -723.18% in 2023, then crashed by 14,746bps to -870.64% in 2024, then plummeted by 45,391bps to -1,005.08% in 2025.
  • Its Operating Margin stands at -1,005.08% for Q3 2025, versus -1,416.22% for Q2 2025 and -660.93% for Q1 2025.